Lyotropic liquid crystal preconcentrates for the treatment of periodontal disease

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 23-26

  Feher A ^a   Urban E ^a   Eros, I ^a   Szabo Revesz P ^a   Csanyi E ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Drug release; Kirby Bauer disk diffusion method; Lyotropic liquid crystals; Periodontal disease

Indexed keywords

BENZOYL METRONIDAZOLE; CREMOPHOR; METRONIDAZOLE; MIGLYOL; MIGLYOL 810; WATER;

ANALYTIC METHOD; ANISOTROPY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DISK DIFFUSION; DRUG STRUCTURE; FLOW KINETICS; IN VITRO STUDY; LIQUID CRYSTAL; MICROSCOPY; PERIODONTAL DISEASE; POLARIZATION; PRIORITY JOURNAL; VISCOSITY; WATER ABSORPTION;

ABSORPTION; ANISOTROPY; DIFFUSION; DRUG CARRIERS; EXCIPIENTS; KINETICS; LIQUID CRYSTALS; OILS; PERIODONTAL DISEASES; POLYETHYLENE GLYCOLS; RHEOLOGY; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES; VISCOSITY;

EID: 44449176973     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.02.025     Document Type: Article

References (19)

1. Armitage G.C. Periodontal diagnoses and classification of periodontal diseases. Periodontol. 2000 34 (2004) 9-21
2. Bauer A.W., Kirby W.M., Sherris J.C., and Turck M. Antibiotic susceptibility testing by a standardized single disk method. Tech. Bull. Regist. Med. Technol. 36 (1996) 49-52
3. Bertram U., and Bodmeier R. Parameters affecting the drug release from in situ gelling nasal inserts. Eur. J. Pharm. Biopharm. 63 (2006) 310-319
4. Chang J.Y., Oh Y.K., Choi H.G., Kim Y.B., and Kim C.K. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int. J. Pharm. 241 (2002) 155-163
5. Edsman K., Carlfors J., and Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 6 (1998) 105-112
6. Greenstein G., and Polson A. The role of local drug delivery in the management of periodontal diseases: a comprehensive review. J. Periodontol. 69 (1998) 507-520
7. Haglund B.O., Joshi R., and Himmelstein K.J. An in situ gelling system for parenteral delivery. J. Control. Release 41 (1996) 229-235
8. Kubo W., Miyazaki S., and Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int. J. Pharm. 258 (2003) 55-64
9. List P.H. Arzneiformenlehre. Ein Lehrbuch für Pharmazeuten. 4 Auflage (1985), Wissenschaftlicher Verlag GmbH, Stuttgart
10. Negishi M., Hiroki A., Horikoshi Y., Miyajima M., Asano M., Katakai R., and Yoshida M. Swelling and ketoprofen release characteristics of thermo- and pH-responsive copolymer gels. Drug Dev. Ind. Pharm. 4 (1999) 437-444
11. Peng Y., Han B., Liu W., and Xu X. Preparation and antimicrobial activity of hydoxypropyl chitosan. Carbohydr. Res. 340 (2005) 1846-1851
12. Pihlstrom B.L., Michalowicz B.S., and Johnson N.W. Periodontal diseases. Lancet 366 (2005) 1809-1820
13. Scherlund, M., 2000. In situ gelling drug delivery systems for periodontal anaesthesia. Ph.D. Thesis, Uppsala University, Sweden.
14. Schram G. A Practical Approach to Rheology and Rheometry. second ed. (2000), Gebrueder HAAKE GmbH, Karlsruhe
15. Schwach-Abdellaoui K., Vivien-Castioni N., and Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur. J. Pharm. Biopharm. 50 (2000) 83-99
16. Seymour R.A., and Heasman P.A. Pharmacological control of periodontal disease II. Antimicrobial agents. J. Dent. 23 (1995) 5-14
17. Tsai I.S., Tsai C.C., Ho Y.P., Ho K.Y., Wu Y.M., and Hung C.C. Interleukin-12 and interleukin-16 in periodontal disease. Cytokine 31 (2005) 34-40
18. Vernon B.L., Fusaro F., Borden B., and Roy K.H. Partition-controlled progesterone release from waterborne, in situ-gelling materials. Int. J. Pharm. 274 (2004) 191-200
19. Wang P.L., and Johnston T.P. Sustained-release interleukin-2 following intramuscular injection in rats. Int. J. Pharm. 113 (1995) 73-81